A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
Clinical trial NCT04020055 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04020055
- Sponsor
- Amicus Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2026-12-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.